MOPEAD project publishes third and final Newsletter

27/12/2019

On 27 December, the Innovative Medicines Initiative funded MOPEAD project launched its third and final newsletter. The newsletter brings all the latest news from the project together, including reflections on the 3-year MOPEAD journey from the project leadership Mercè Boada and Laura Campo. It also includes articles on key achievements of the project.

You can download a pdf version here.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations.